KIG
COLL icon

Kowal Investment Group’s Collegium Pharmaceutical COLL Stock Holding History

Kowal Investment Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 289
2021
Q3 		$0 Buy
+1
New +$22 ﹤0.01% 930

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kowal Investment Group's COLL Position: Q4 2021 in Review

Kowal Investment Group sold out of Collegium Pharmaceutical (COLL) in Q4 2021, closing a stake of 1 share.

Kowal Investment Group first reported a position in COLL in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 159 funds tracked by Wall St. Rank hold COLL as of Q4 2021.

  • Kowal Investment Group reported no remaining Collegium Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Kowal Investment Group sold 1 Collegium Pharmaceutical share in Q4 2021.
  • Kowal Investment Group first reported a position in Collegium Pharmaceutical in Q3 2021 and held it in 1 quarter.
  • Kowal Investment Group's Collegium Pharmaceutical position peaked at $0 in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.